article thumbnail

Incyte replaces CEO Hoppenot with dealmaker Meury

BioPharma Drive: Drug Pricing

“During Hervé’s tenure, Incyte launched six novel medicines plus two new indications for Jakafi, expanded commercial operations into Europe, Japan and Canada and grew revenues from $355 million dollars in 2013 to $4.2 says US won’t donate to global vaccine effort View all Events 07 JUL Webinar | 10 a.m. billion today.”

Licensing 124
article thumbnail

HOOKIPA Announces Positive Phase 2 Interim Safety, Immunogenicity, and Efficacy Data for its Cytomegalovirus Vaccine Candidate HB-101

The Pharma Data

Early interim data show Cytomegalovirus (CMV)-negative kidney transplant recipients vaccinated with three doses of HB-101 had reduced incidence of CMV viremia, reduced antiviral use and no CMV disease. 21 participants were vaccinated with HB-101 and 12 received placebo. NEW YORK and VIENNA, Austria, Nov.

Vaccine 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Article FDA Thank You Vaccines advisory panel endorses move to trivalent formulation for U.S. flu vaccines

Agency IQ

Vaccines advisory panel endorses move to trivalent formulation for U.S. flu vaccines Yesterday, FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) weighed in on strains for seasonal influenza vaccines for the Northern hemisphere 2024-2025 season.

Vaccine 40
article thumbnail

FDA Authorizes Phase 1 Trial of ImmunityBio’s Novel COVID-19 Vaccine Candidate hAd5; Dual Construct is Designed to Drive Both T Cell and Antibody Immunity

The Pharma Data

Food and Drug Administration (FDA) to begin a Phase I clinical trial of hAd5-COVID-19, the company’s novel COVID-19 vaccine candidate that targets both the inner nucleocapsid (N), engineered to activate T cells, and outer spike (S) protein, engineered to activate antibodies against the coronavirus (SARS-CoV-2).

Vaccine 40
article thumbnail

Spade SB-66

The Pharma Data

Evidence-Based Complementary and Alternative Medicine, 2013. [15] And I can’t wait to hear about the difference Spade SB-66 has made in your life. [14] 14] Ambiye, V. Langade, D., Aptikar, P., Kulkarni, M., & Dongre, A. 15] Dongre, S., Langade, D., & Bhattacharyya, S. BioMed research international, 2015. [16] 16] Choudhary, B.,

article thumbnail

Discovering an Antimalarial Drug in Mao’s China

Codon

Current vaccines and medicines work by intervening against these life phases. only issued “the strongest ‘black box’ warning” against the drug in 2013. Multiple species of Plasmodium infect humans, but P. falciparum is the most prevalent and has killed more people than any other.

Drugs 141
article thumbnail

The Collaboration Between Industry and Academia in Drug Development

DrugBank

One example is the development of mRNA vaccines, which were developed in academic labs by prominent scientists such as Katalin Kariko (Nobel Prize Laureate 2023) before being commercialized by companies like Moderna and Pfizer/BioNTech to combat the COVID-19 pandemic.